UniQure to seek FDA approval for Huntington’s disease gene therapy after previous clash with agency
The announcement comes months after UniQure became embroiled in a public debate with FDA leaders over the clinical trial data supporting its application.
The Source
CNBC
Business
Here are the five big takeaways from Kevin Warsh’s first meeting as Fed chairman
CNBC·46m ago·3 min read
US
Analysis: Chairman Kevin Warsh’s task forces are the key to understanding the new Fed
CNBC·33m ago·3 min read
US
Fed holds rates steady, pares down statement to remove cutting bias
CNBC·2h ago·3 min read
US
Chairman Warsh drastically alters Fed rate statement. Here’s what’s changed
CNBC·2h ago·3 min read
Related
On this beat
Business
Grocery chain pays massive fine, accused of inflated price reporting
THE STREET·1h ago·3 min read
Business
Can a TikTok Voice Actor Actually Resurrect Spirit Airlines? Inside the $25 Million Rescue Plan
INC·1h ago·3 min read
Business
Smith & Wesson Posts Higher Profit on Strong Handgun Sales
TWSJ·1h ago·3 min read
Business
Fed holds rates steady at Warsh’s first meeting.
TNYT·55m ago·3 min read
